Saudi Arabia’s Capital Markets Authority (CMA) approved Specialized Medical Company’s application to register its shares and proceed with an initial public offering of 75,000,000 shares, representing 30% of the company’s share capital. The prospectus is due to be published sufficiently ahead of the subscription period and will include key information for investors, including the company’s financial statements, activities and management, and risk factors. The CMA stressed that its approval is not a recommendation to subscribe, but an acknowledgement that the legal requirements under the Capital Market Law and its Implementing Regulations have been met. The approval is valid for six months from the CMA Board resolution date and will be cancelled if the offering and listing are not completed within that period.
Saudi Arabia Capital Markets Authority 2025-03-26
Saudi Arabia Capital Markets Authority approves Specialized Medical Company registration and IPO of 75 million shares
Saudi Arabia’s Capital Markets Authority approved Specialized Medical Company’s application to offer 75,000,000 shares, 30% of its share capital, in an initial public offering. The prospectus will be published before the subscription period, detailing financial statements, activities, management, and risk factors. The approval is valid for six months and void if not completed within this timeframe.